Are cannabis use problems comparable across individuals using for recreational and medical purposes? An international cross-sectional study of individuals who use self-grown cannabis.

Cannabis growers Medical cannabis use Recreational cannabis use Risk factors Severity of dependence scale

Journal

The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759

Informations de publication

Date de publication:
11 Dec 2023
Historique:
received: 14 07 2023
revised: 10 11 2023
accepted: 12 11 2023
medline: 13 12 2023
pubmed: 13 12 2023
entrez: 13 12 2023
Statut: aheadofprint

Résumé

Little is known about cannabis use problems among individuals who use cannabis for medical purposes and whether rates and determinants of cannabis use problems in medical users differ to those observed among individuals using for recreational reasons. This study examines whether Severity of Dependence Scale (SDS) scores differ across individuals who use self-grown cannabis for the following reasons: "recreational only", "medical and recreational" and "medical only". Furthermore, the study tests whether cannabis use frequency, cannabis strain, and type of cannabis influences the strength of the association between purpose of use and cannabis use problems. Data (n = 5,347) were collected from a subsample of the Global Cannabis Cultivation Research Consortium project, focusing on small-scale cannabis growers in 18 countries. Robust regressions analyzed differences in SDS scores across the three use motivation groups. Compared with respondents reporting only recreational motivations of cannabis use, those with medical (with and without recreational) motivations were associated with lower SDS scores (B: -0.190 and B: -0.459, p < 0.001 respectively). Daily use was associated with significantly higher SDS scores across all cannabis motivation groups, albeit the magnitude of the association was significantly smaller among individuals with medical motivations of use. The extent to which people experience cannabis use problems, and the determinants of these problems may differ depending on whether cannabis use is motivated by recreational or medical purposes. As such, the findings of the current study suggest that public education efforts, harm reduction approaches and policy responses should be tailored depending on whether cannabis is used for recreational or medical purposes.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about cannabis use problems among individuals who use cannabis for medical purposes and whether rates and determinants of cannabis use problems in medical users differ to those observed among individuals using for recreational reasons. This study examines whether Severity of Dependence Scale (SDS) scores differ across individuals who use self-grown cannabis for the following reasons: "recreational only", "medical and recreational" and "medical only". Furthermore, the study tests whether cannabis use frequency, cannabis strain, and type of cannabis influences the strength of the association between purpose of use and cannabis use problems.
METHODS METHODS
Data (n = 5,347) were collected from a subsample of the Global Cannabis Cultivation Research Consortium project, focusing on small-scale cannabis growers in 18 countries. Robust regressions analyzed differences in SDS scores across the three use motivation groups.
RESULTS RESULTS
Compared with respondents reporting only recreational motivations of cannabis use, those with medical (with and without recreational) motivations were associated with lower SDS scores (B: -0.190 and B: -0.459, p < 0.001 respectively). Daily use was associated with significantly higher SDS scores across all cannabis motivation groups, albeit the magnitude of the association was significantly smaller among individuals with medical motivations of use.
CONCLUSION CONCLUSIONS
The extent to which people experience cannabis use problems, and the determinants of these problems may differ depending on whether cannabis use is motivated by recreational or medical purposes. As such, the findings of the current study suggest that public education efforts, harm reduction approaches and policy responses should be tailored depending on whether cannabis is used for recreational or medical purposes.

Identifiants

pubmed: 38087710
pii: S0955-3959(23)00310-9
doi: 10.1016/j.drugpo.2023.104263
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104263

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict declared.

Auteurs

Sharon R Sznitman (SR)

School of Public Health, University of Haifa, Israel. Electronic address: sznitman@research.haifa.ac.il.

Gary R Potter (GR)

Lancaster University Law School, Lancaster, UK.

Jodie Grigg (J)

National Drug Research Institute & enAble Institute, Department of Health Sciences, Curtin University, Australia.

Ashely Granville (A)

École des Sciences Criminelles, Faculté de Droit, Université de Lausanne, Switzerland.

Pekka Hakkarainen (P)

Finnish Institute for Health and Welfare.

Tom Decorte (T)

Institute for Social Drug Research (ISD), Ghent University.

Simon Lenton (S)

National Drug Research Institute & enAble Institute, Department of Health Sciences, Curtin University, Perth, Australia.

Davide Fortin (D)

Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Daniel Bear (D)

Faculty of Social and Community Services, Humber College.

Irma Kirtadze (I)

Faculty of Arts and Sciences, Ilia State University, Tbilisi, Georgia.

Marie Jauffret-Roustide (M)

Centre d'étude des mouvements sociaux (Inserm U 1276/CNRS UMR 8044/EHESS), Paris, France; British Columbia Center on Substance Use, Vancouver, Canada; Baldy Center on Law and Social Policy, Buffalo, NY, USA.

Monica J Barratt (MJ)

Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University, Melbourne, Vic, Australia; National Drug and Alcohol Research Centre, UNSW Sydney, NSW, Australia.

Eric L Sevigny (EL)

Department of Criminal Justice & Criminology, Andrew Young School of Policy Studies, Georgia State University, 55 Park Place NE, Suite 519, Atlanta, GA 30303, USA.

Classifications MeSH